| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Altering the specificity of NK:target cell interactions by genetic manipulation of NK receptor expression on primary mouse NK cells
|
Tran, Jimmy
|
|
2010
|
28 |
22 |
p. 3767-3772
6 p.
|
artikel
|
| 2 |
Antibodies to serotype 9V exhibit novel serogroup cross-reactivity following infant pneumococcal immunization
|
Licciardi, P.V.
|
|
2010
|
28 |
22 |
p. 3793-3800
8 p.
|
artikel
|
| 3 |
Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination
|
Chlibek, Roman
|
|
2010
|
28 |
22 |
p. 3758-3766
9 p.
|
artikel
|
| 4 |
Co-expression of Flt-3 ligand gene ablates tumor immunity elicited by HER-2/neu DNA vaccine in transgenic mice
|
Venanzi, F.M.
|
|
2010
|
28 |
22 |
p. 3841-3847
7 p.
|
artikel
|
| 5 |
Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells
|
Hussain, Althaf I.
|
|
2010
|
28 |
22 |
p. 3848-3855
8 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
2010
|
28 |
22 |
p. CO2-
1 p.
|
artikel
|
| 7 |
Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+ T cells in vivo
|
Bayard, Florence
|
|
2010
|
28 |
22 |
p. 3818-3826
9 p.
|
artikel
|
| 8 |
Identification of a novel vaccine adjuvant that stimulates and maintains diphtheria toxoid immunity
|
Licciardi, Paul V.
|
|
2010
|
28 |
22 |
p. 3865-3873
9 p.
|
artikel
|
| 9 |
Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves
|
Xue, Wenzhi
|
|
2010
|
28 |
22 |
p. 3784-3792
9 p.
|
artikel
|
| 10 |
Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity
|
Monath, Thomas P.
|
|
2010
|
28 |
22 |
p. 3827-3840
14 p.
|
artikel
|
| 11 |
Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians
|
Chow, Song-Nan
|
|
2010
|
28 |
22 |
p. 3809-3817
9 p.
|
artikel
|
| 12 |
Potential epidemiological and economical impact of two rotavirus vaccines in Colombia
|
De la Hoz, Fernando
|
|
2010
|
28 |
22 |
p. 3856-3864
9 p.
|
artikel
|
| 13 |
Regrettable lack of definition of the “well tolerated” vaccine
|
Scheifele, David
|
|
2010
|
28 |
22 |
p. 3755-3756
2 p.
|
artikel
|
| 14 |
Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection
|
Kim, Sol
|
|
2010
|
28 |
22 |
p. 3801-3808
8 p.
|
artikel
|
| 15 |
The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature
|
Alavian, Seyed-Moayed
|
|
2010
|
28 |
22 |
p. 3773-3777
5 p.
|
artikel
|
| 16 |
The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox
|
Heinsbroek, Ellen
|
|
2010
|
28 |
22 |
p. 3778-3783
6 p.
|
artikel
|
| 17 |
Two adult vaccination survey papers
|
Lazarsfeld, Rodney
|
|
2010
|
28 |
22 |
p. 3757-
1 p.
|
artikel
|
Tijdschrift beschrijving